• Users Online: 1361
  • Print this page
  • Email this page

    Article Cited by others


Ineffectiveness of tumor necrosis factor-α blockers and ustekinumab in a case of type IV pityriasis rubra pilaris

Lernia Vito Di, Ficarelli Elena, Zanelli Magda

Year : 2015| Volume: 6| Issue : 3 | Page no: 207-209

   This article has been cited by
1 Biologics for pityriasis rubra pilaris treatment: A review of the literature
Monica Napolitano,Damiano Abeni,Biagio Didona
Journal of the American Academy of Dermatology. 2018;
[Pubmed]  [Google Scholar] [DOI]
2 Pityriasis rubra pilaris: algorithms for diagnosis and treatment
S. Roenneberg,T. Biedermann
Journal of the European Academy of Dermatology and Venereology. 2018;
[Pubmed]  [Google Scholar] [DOI]
3 A Review on Pityriasis Rubra Pilaris
Dingyuan Wang,Vanessa Cui-Lian Chong,Wei-Sheng Chong,Hazel H. Oon
American Journal of Clinical Dermatology. 2018;
[Pubmed]  [Google Scholar] [DOI]
4 Off-Label uses of Biologic Agents Approved for Psoriasis and Psoriatic Arthritis for Dermatological Conditions: Part II
Amira Elbendary,Roselyn Kellen
Journal of Psoriasis and Psoriatic Arthritis. 2017; 2(2): 65
[Pubmed]  [Google Scholar] [DOI]
5 Ustekinumab treatment of pityriasis rubra pilaris: A report of five cases
Monica Napolitano,Luigi Lembo,Luca Fania,Damiano Abeni,Dario Didona,Biagio Didona
The Journal of Dermatology. 2017;
[Pubmed]  [Google Scholar] [DOI]


Read this article